Press releaseGlobe Newswire
TELA Bio
TELA · NASDAQ
$1.09+$0.1197 (+12.34%)TodayMarket closed ·
Prev close $0.9703
Latest news
- NewsAvi Kapoor
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
- News
TELA Bio Announces $17M Annual Expense Reduction Through 20% Workforce Streamlining and Resource Optimization, Extending Cash Runway Into 2028
- Press releaseGlobe Newswire
TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative
- Press releaseGlobe Newswire
TELA Bio to Announce Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead
- News
TELA Bio Q1 2026 Earnings Call Transcript
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
Earnings Scheduled For May 12, 2026
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
TELA Bio to Announce First Quarter 2026 Financial Results
- NewsVandana Singh
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly
- NewsAvi Kapoor
Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- News
Earnings Scheduled For May 8, 2025
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
Deep Dive Into TELA Bio Stock: Analyst Perspectives (6 Ratings)
- News
Demystifying TELA Bio: Insights From 6 Analyst Reviews
- NewsAvi Kapoor
Crude Oil Down 2%; Paysafe Shares Surge After Q2 Results
- NewsAvi Kapoor
S&P 500 Gains 1%; Home Depot Earnings Top Views
- NewsAvi Kapoor
Nasdaq Surges 200 Points; US Producer Prices Increase 0.1% In July
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.